EMBC

Embecta Corp. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2025-11-25

Figures on this page computed 2026-11-08 12:24 UTC

Last close

6.52USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2025-11-25

3.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
- computed
- 10-K for 2025, filed 2025-11-25
The filing itself
29.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
- 10-Q for 2025, filed 2026-08-07
- 10-K for 2025, filed 2025-11-25
- 10-Q for 2025, filed 2026-08-07
The filing itself
8.8%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
The filing itself
16.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
- 10-K for 2025, filed 2025-11-25
- 10-Q for 2025, filed 2026-08-07
The filing itself
5.2%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2025-11-25

Growth is the furthest below its sector's middle: 0.28 against 0.47 on the market's range.

All from 100

lens 2 of 9

Sales

99.5

2020-09-30 to 2025-09-30100 at the start99.5

Sales: 100.00 on 2020-09-30 to 99.53 on 2025-09-30, down 0%.

Profit

22.3

2020-09-30 to 2025-09-30100 at the start22.3

Profit: 100.00 on 2020-09-30 to 22.31 on 2025-09-30, down 78%.

Shares in issue

103

2020-09-30 to 2025-09-30100 at the start103

Shares in issue: 100.00 on 2020-09-30 to 103.34 on 2025-09-30, up 3%.

Sales is at 100, Profit is at 22, Shares in issue is at 103, against 100 in 2020.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2025-11-25

Sales, where the first year is 100100
Source
filed
Statement
income
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
The filing itself
Profit, where the first year is 10022
Source
filed
Statement
income
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
The filing itself
Shares in issue, where the first year is 100103
Source
filed
Statement
income
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
The filing itself